Cannabidiol as a potential new type of an antipsychotic. A critical review of the evidence
There is urgent need for the development of mechanistically different and less side-effect prone antipsychotic compounds. The endocannabinoid system has been suggested to represent a potential new target in this indication. While the chronic use of cannabis itself has been considered a risk factor c...
Saved in:
Main Authors: | Cathrin Rohleder (Author), Juliane K. Mueller (Author), Bettina Lange (Author), F. Markus Leweke (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2016-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cannabidiol and Amisulpride Improve Cognition in Acute Schizophrenia in an Explorative, Double-Blind, Active-Controlled, Randomized Clinical Trial
by: F. Markus Leweke, et al.
Published: (2021) -
Cannabidiol as a potential treatment for psychosis
by: Cathy Davies, et al.
Published: (2019) -
The therapeutic potential of purified cannabidiol
by: Saoirse Elizabeth O'Sullivan, et al.
Published: (2023) -
Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the Evidence
by: Mélissa Prud'homme, et al.
Published: (2015) -
Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the Evidence
by: Mélissa Prud'homme, et al.
Published: (2015)